{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 7,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 1
      },
      "2": {
        "core": 1,
        "branch": 0
      },
      "3": {
        "core": 1,
        "branch": 1
      },
      "4": {
        "core": 1,
        "branch": 1
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A10 → (A8 ∨ A9))",
        "prover9_expression": "(quality_test_failure(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
        "natural": "If batch Z fails quality testing, then either excipient Y experiences raw material shortage or excipient Y experiences supplier delay."
      },
      {
        "id": "Rule2",
        "formal": "(A10 ∨ A11)",
        "prover9_expression": "(quality_test_failure(batch_z) | contamination_detected(batch_z))",
        "natural": "Either batch Z fails quality testing or contamination is detected in batch Z."
      },
      {
        "id": "Rule3",
        "formal": "(A11 → (A8 ∨ A9))",
        "prover9_expression": "(contamination_detected(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
        "natural": "Provided that contamination is detected in batch Z, it follows that either excipient Y has raw material shortage or excipient Y has supplier delay."
      },
      {
        "id": "Rule4",
        "formal": "(A13 → (A12 ∨ G))",
        "prover9_expression": "(accelerated_aging_test(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
        "natural": "Whenever formulation W undergoes accelerated aging testing, either formulation W passes stability study or compound X becomes profitable."
      },
      {
        "id": "Rule5",
        "formal": "(A13 ∨ A14)",
        "prover9_expression": "(accelerated_aging_test(formulation_w) | real_time_stability(formulation_w))",
        "natural": "Formulation W undergoes accelerated aging testing or formulation W undergoes real-time stability testing."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → A15)",
        "prover9_expression": "(batch_rejection(batch_z) -> product_recall(batch_z))",
        "natural": "If batch Z is rejected, then batch Z is subject to product recall."
      },
      {
        "id": "Rule7",
        "formal": "(A17 → (¬(A14 → (A12 ∨ G)) → A16))",
        "prover9_expression": "(quality_control_inspection(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
        "natural": "Provided that plant A undergoes quality control inspection, if it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
      },
      {
        "id": "Rule8",
        "formal": "(A17 ∨ A18)",
        "prover9_expression": "(quality_control_inspection(plant_a) | audit_finding(plant_a))",
        "natural": "Either plant A undergoes quality control inspection or plant A has audit findings."
      },
      {
        "id": "Rule9",
        "formal": "(A18 → (¬(A14 → (A12 ∨ G)) → A16))",
        "prover9_expression": "(audit_finding(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
        "natural": "Whenever plant A has audit findings, if it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
      },
      {
        "id": "Rule10",
        "formal": "(A20 → A21)",
        "prover9_expression": "(patent_filing(compound_x) -> intellectual_property(compound_x))",
        "natural": "Provided that compound X has patent filing, it follows that compound X has intellectual property protection."
      },
      {
        "id": "Rule11",
        "formal": "(A22 → (A21 → A19))",
        "prover9_expression": "(prior_art_search(compound_x) -> (intellectual_property(compound_x) -> patent_protection(compound_x)))",
        "natural": "Under the condition that compound X undergoes prior art search, if compound X has intellectual property protection then compound X has patent protection."
      },
      {
        "id": "Rule12",
        "formal": "(A24 → (¬A22 → A23))",
        "prover9_expression": "(process_validation(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
        "natural": "If manufacturing line B undergoes process validation, then provided that compound X does not undergo prior art search, compound X receives patent rejection."
      },
      {
        "id": "Rule13",
        "formal": "(A25 → (¬A22 → A23))",
        "prover9_expression": "(equipment_qualification(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
        "natural": "Whenever manufacturing line B has equipment qualification, if compound X does not undergo prior art search then compound X receives patent rejection."
      },
      {
        "id": "Rule14",
        "formal": "(A26 → A24)",
        "prover9_expression": "(validation_protocol(manufacturing_line_b) -> process_validation(manufacturing_line_b))",
        "natural": "If manufacturing line B has validation protocol, then manufacturing line B undergoes process validation."
      },
      {
        "id": "Rule15",
        "formal": "(A26 ∨ A27)",
        "prover9_expression": "(validation_protocol(manufacturing_line_b) | qualification_study(manufacturing_line_b))",
        "natural": "Either manufacturing line B has validation protocol or manufacturing line B has qualification study."
      },
      {
        "id": "Rule16",
        "formal": "(A27 → A25)",
        "prover9_expression": "(qualification_study(manufacturing_line_b) -> equipment_qualification(manufacturing_line_b))",
        "natural": "Provided that manufacturing line B has qualification study, it follows that manufacturing line B has equipment qualification."
      },
      {
        "id": "Rule17",
        "formal": "(A32 → A12)",
        "prover9_expression": "(dissolution_test(pill_form) -> stability_study_pass(formulation_w))",
        "natural": "If pill form undergoes dissolution testing, then formulation W passes stability study."
      },
      {
        "id": "Rule18",
        "formal": "(A33 → G)",
        "prover9_expression": "(bioavailability_study(pill_form) -> profitable_product(compound_x))",
        "natural": "Under the condition that pill form undergoes bioavailability study, compound X becomes profitable."
      },
      {
        "id": "Rule19",
        "formal": "(A35 → A36)",
        "prover9_expression": "(excipient_modification(compound_x) -> delivery_system_update(compound_x))",
        "natural": "Provided that compound X has excipient modifications, compound X has delivery system updates."
      },
      {
        "id": "Rule20",
        "formal": "(A4 → A3)",
        "prover9_expression": "(market_authorization(compound_x) -> regulatory_approval(compound_x))",
        "natural": "If compound X receives market authorization, then compound X obtains regulatory approval."
      },
      {
        "id": "Rule21",
        "formal": "(A40 → A39)",
        "prover9_expression": "(equipment_upgrade(manufacturing_line_b) -> process_improvement(manufacturing_line_b))",
        "natural": "Whenever manufacturing line B has equipment upgrades, manufacturing line B has process improvements."
      },
      {
        "id": "Rule22",
        "formal": "(A41 → (¬(A24 ∨ A25) → A40))",
        "prover9_expression": "(capa_implementation(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
        "natural": "Provided that manufacturing line B has CAPA implementation, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
      },
      {
        "id": "Rule23",
        "formal": "(A41 ∨ A42)",
        "prover9_expression": "(capa_implementation(manufacturing_line_b) | deviation_management(manufacturing_line_b))",
        "natural": "Either manufacturing line B has CAPA implementation or manufacturing line B has deviation management."
      },
      {
        "id": "Rule24",
        "formal": "(A42 → (¬(A24 ∨ A25) → A40))",
        "prover9_expression": "(deviation_management(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
        "natural": "Under the condition that manufacturing line B has deviation management, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
      },
      {
        "id": "Rule25",
        "formal": "(A5 ∨ A6)",
        "prover9_expression": "(production_scale_up(compound_x) | manufacturing_optimization(compound_x))",
        "natural": "Either compound X undergoes production scale-up or compound X undergoes manufacturing optimization."
      },
      {
        "id": "Rule26",
        "formal": "(A6 → G)",
        "prover9_expression": "(manufacturing_optimization(compound_x) -> profitable_product(compound_x))",
        "natural": "Whenever compound X undergoes manufacturing optimization, compound X becomes profitable."
      },
      {
        "id": "Rule27",
        "formal": "(A7 ∨ (A5 → G))",
        "prover9_expression": "(supply_chain_issue(compound_x) | (production_scale_up(compound_x) -> profitable_product(compound_x)))",
        "natural": "Either compound X experiences supply chain issues or if compound X undergoes production scale-up then compound X is profitable."
      },
      {
        "id": "Rule28",
        "formal": "(A8 → ¬A7)",
        "prover9_expression": "(raw_material_shortage(excipient_y) -> -supply_chain_issue(compound_x))",
        "natural": "If excipient Y has raw material shortage, then compound X does not experience supply chain issues."
      },
      {
        "id": "Rule29",
        "formal": "(A9 → ¬A7)",
        "prover9_expression": "(supplier_delay(excipient_y) -> -supply_chain_issue(compound_x))",
        "natural": "Provided that excipient Y has supplier delay, compound X does not experience supply chain issues."
      },
      {
        "id": "Rule30",
        "formal": "(¬(A14 → (A12 ∨ G)) → ¬A15)",
        "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> -product_recall(batch_z))",
        "natural": "Provided that it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is not subject to product recall."
      },
      {
        "id": "Rule31",
        "formal": "(¬(A24 ∨ A25) → ¬A39)",
        "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> -process_improvement(manufacturing_line_b))",
        "natural": "Whenever it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B does not have process improvements."
      },
      {
        "id": "Rule32",
        "formal": "(¬(A28 → A3) → A29)",
        "prover9_expression": "(-(phase_iii_completion(compound_x) -> regulatory_approval(compound_x)) -> efficacy_data(compound_x))",
        "natural": "If it is not the case that whenever compound X completes Phase III trials then compound X obtains regulatory approval, then compound X has efficacy data."
      },
      {
        "id": "Rule33",
        "formal": "(¬(A30 ∨ ¬A29) → A31)",
        "prover9_expression": "(-(safety_profile(compound_x) | -efficacy_data(compound_x)) -> adverse_events(compound_x))",
        "natural": "Provided that it is not the case that either compound X has safety profile data or compound X does not have efficacy data, compound X has adverse events."
      },
      {
        "id": "Rule34",
        "formal": "(¬(A32 ∨ A33) → A35)",
        "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> excipient_modification(compound_x))",
        "natural": "Whenever it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has excipient modifications."
      },
      {
        "id": "Rule35",
        "formal": "(¬(A32 ∨ A33) → ¬A34)",
        "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> -formulation_change(compound_x))",
        "natural": "If it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, then compound X does not have formulation changes."
      },
      {
        "id": "Rule36",
        "formal": "(¬(A37 ∨ (A36 → A34)) → A38)",
        "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> packaging_redesign(compound_x))",
        "natural": "Provided that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X has packaging redesign."
      },
      {
        "id": "Rule37",
        "formal": "(¬(A37 ∨ (A36 → A34)) → ¬A38)",
        "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> -packaging_redesign(compound_x))",
        "natural": "Under the condition that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X does not have packaging redesign."
      },
      {
        "id": "Rule38",
        "formal": "(¬(¬(¬G → ¬A1) → A2) → A28)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> phase_iii_completion(compound_x))",
        "natural": "If it is not the case that whenever it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, then compound X completes Phase III trials."
      },
      {
        "id": "Rule39",
        "formal": "(¬(¬(¬G → ¬A1) → A2) → A4)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> market_authorization(compound_x))",
        "natural": "Whenever it is not the case that if it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X receives market authorization."
      },
      {
        "id": "Rule40",
        "formal": "(¬(¬(¬G → ¬A1) → A2) → ¬A3)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> -regulatory_approval(compound_x))",
        "natural": "Under the condition that it is not the case that provided that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X does not obtain regulatory approval."
      },
      {
        "id": "Rule41",
        "formal": "(¬(¬G → ¬A1) → ¬A2)",
        "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> -clinical_trial_success(compound_x))",
        "natural": "Provided that it is not the case that if compound X is not profitable then compound X is not approved for research, compound X does not have clinical trial success."
      },
      {
        "id": "Rule42",
        "formal": "(¬A22 → ¬A23)",
        "prover9_expression": "(-prior_art_search(compound_x) -> -patent_rejection(compound_x))",
        "natural": "Under the condition that compound X does not undergo prior art search, compound X does not receive patent rejection."
      },
      {
        "id": "Rule43",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-profitable_product(compound_x) -> approved_for_research(compound_x))",
        "natural": "If compound X is not profitable, then compound X is approved for research."
      },
      {
        "id": "Rule44",
        "formal": "(¬G → A20)",
        "prover9_expression": "(-profitable_product(compound_x) -> patent_filing(compound_x))",
        "natural": "Whenever compound X is not profitable, compound X has patent filing."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "¬A12",
        "prover9_expression": "-stability_study_pass(formulation_w)",
        "natural": "Formulation W does not pass stability study."
      },
      {
        "id": "Fact2",
        "formal": "¬A19",
        "prover9_expression": "-patent_protection(compound_x)",
        "natural": "Compound X does not have patent protection."
      },
      {
        "id": "Fact3",
        "formal": "¬A30",
        "prover9_expression": "-safety_profile(compound_x)",
        "natural": "Compound X does not have safety profile data."
      },
      {
        "id": "Fact4",
        "formal": "¬A31",
        "prover9_expression": "-adverse_events(compound_x)",
        "natural": "Compound X does not have adverse events."
      },
      {
        "id": "Fact5",
        "formal": "¬A37",
        "prover9_expression": "-shelf_life_extension(compound_x)",
        "natural": "Compound X does not have shelf life extension."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "profitable_product(compound_x)",
    "natural": "Compound X is a profitable product."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(-G -> -A1) -> A2) -> A4)",
            "(A4 -> A3)"
          ],
          "conclusion": "(-(-(-G -> -A1) -> A2) -> A3)",
          "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-G -> -A1) -> A2) -> A3)",
            "(-(-(-G -> -A1) -> A2) -> -A3)"
          ],
          "conclusion": "(-(-G -> -A1) -> A2)",
          "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-G -> -A1) -> A2)",
            "(-(-G -> -A1) -> -A2)"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A10 | A11)",
            "(A10 -> (A8 | A9))",
            "(A11 -> (A8 | A9))"
          ],
          "conclusion": "(A8 | A9)",
          "natural": "Either excipient Y has raw material shortage or excipient Y has supplier delay."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A8 | A9)",
            "(A8 -> -A7)",
            "(A9 -> -A7)"
          ],
          "conclusion": "-A7",
          "natural": "Compound X does not experience supply chain issues."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A7 | (A5 -> G))",
            "-A7"
          ],
          "conclusion": "(A5 -> G)",
          "natural": "If compound X undergoes production scale-up, then compound X is profitable."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A5 | A6)",
            "(A5 -> G)",
            "(A6 -> G)"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (-(A14 -> (A12 | G)) -> A16))",
            "(A18 -> (-(A14 -> (A12 | G)) -> A16))"
          ],
          "conclusion": "(-(A14 -> (A12 | G)) -> A16)",
          "natural": "Whenever it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is rejected."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A14 -> (A12 | G)) -> A16)",
            "(A16 -> A15)"
          ],
          "conclusion": "(-(A14 -> (A12 | G)) -> A15)",
          "natural": "If it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is subject to product recall."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A14 -> (A12 | G)) -> A15)",
            "(-(A14 -> (A12 | G)) -> -A15)"
          ],
          "conclusion": "(A14 -> (A12 | G))",
          "natural": "Under the condition that formulation W undergoes real-time stability testing, either formulation W passes stability study or compound X is profitable."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> (A12 | G))",
            "(A14 -> (A12 | G))"
          ],
          "conclusion": "(A12 | G)",
          "natural": "Formulation W passes stability study or compound X is a profitable product."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A12 | G)",
            "-A12"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            "(A26 -> A24)",
            "(A27 -> A25)",
            "(A26 | A27)"
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> (-A22 -> A23))",
            "(A25 -> (-A22 -> A23))"
          ],
          "conclusion": "(-A22 -> A23)",
          "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A22 -> A23)",
            "(-A22 -> -A23)"
          ],
          "conclusion": "A22",
          "natural": "Compound X undergoes prior art search."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (A21 -> A19))",
            "A22"
          ],
          "conclusion": "(A21 -> A19)",
          "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A20 -> A21)",
            "(A21 -> A19)"
          ],
          "conclusion": "(A20 -> A19)",
          "natural": "If compound X has patent filing, then compound X has patent protection."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A20)",
            "(A20 -> A19)"
          ],
          "conclusion": "(-G -> A19)",
          "natural": "Provided that compound X is not profitable, compound X has patent protection."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A19)",
            "-A19"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A30 | -A29) -> A31)",
            "-A31"
          ],
          "conclusion": "(A30 | -A29)",
          "natural": "Either compound X has safety profile data or compound X does not have efficacy data."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A30 | -A29)",
            "-A30"
          ],
          "conclusion": "-A29",
          "natural": "Compound X does not have efficacy data."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A28 -> A3) -> A29)",
            "-A29"
          ],
          "conclusion": "(A28 -> A3)",
          "natural": "Whenever compound X completes Phase III trials, compound X obtains regulatory approval."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(-G -> -A1) -> A2) -> A28)",
            "(A28 -> A3)"
          ],
          "conclusion": "(-(-(-G -> -A1) -> A2) -> A3)",
          "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-G -> -A1) -> A2) -> A3)",
            "(-(-(-G -> -A1) -> A2) -> -A3)"
          ],
          "conclusion": "(-(-G -> -A1) -> A2)",
          "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-G -> -A1) -> A2)",
            "(-(-G -> -A1) -> -A2)"
          ],
          "conclusion": "(-G -> -A1)",
          "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A37 | (A36 -> A34)) -> A38)",
            "(-(A37 | (A36 -> A34)) -> -A38)"
          ],
          "conclusion": "(A37 | (A36 -> A34))",
          "natural": "Either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A37 | (A36 -> A34))",
            "-A37"
          ],
          "conclusion": "(A36 -> A34)",
          "natural": "Whenever compound X has delivery system updates, compound X has formulation changes."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A35 -> A36)",
            "(A36 -> A34)"
          ],
          "conclusion": "(A35 -> A34)",
          "natural": "If compound X has excipient modifications, then compound X has formulation changes."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A32 | A33) -> A35)",
            "(A35 -> A34)"
          ],
          "conclusion": "(-(A32 | A33) -> A34)",
          "natural": "Under the condition that it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has formulation changes."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A32 | A33) -> A34)",
            "(-(A32 | A33) -> -A34)"
          ],
          "conclusion": "(A32 | A33)",
          "natural": "Either pill form undergoes dissolution testing or pill form undergoes bioavailability study."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A32 -> A12)",
            "(A33 -> G)",
            "(A32 | A33)"
          ],
          "conclusion": "(A12 | G)",
          "natural": "Formulation W passes stability study or compound X is a profitable product."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A12 | G)",
            "-A12"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A41 | A42)",
            "(A41 -> (-(A24 | A25) -> A40))",
            "(A42 -> (-(A24 | A25) -> A40))"
          ],
          "conclusion": "(-(A24 | A25) -> A40)",
          "natural": "Under the condition that it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B has equipment upgrades."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A24 | A25) -> A40)",
            "(A40 -> A39)"
          ],
          "conclusion": "(-(A24 | A25) -> A39)",
          "natural": "If it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has process improvements."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A24 | A25) -> A39)",
            "(-(A24 | A25) -> -A39)"
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> (-A22 -> A23))",
            "(A25 -> (-A22 -> A23))"
          ],
          "conclusion": "(-A22 -> A23)",
          "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A22 -> A23)",
            "(-A22 -> -A23)"
          ],
          "conclusion": "A22",
          "natural": "Compound X undergoes prior art search."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (A21 -> A19))",
            "A22"
          ],
          "conclusion": "(A21 -> A19)",
          "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
        },
        {
          "step_number": 7,
          "rule_applied": "HS",
          "premises_used": [
            "(A20 -> A21)",
            "(A21 -> A19)"
          ],
          "conclusion": "(A20 -> A19)",
          "natural": "If compound X has patent filing, then compound X has patent protection."
        },
        {
          "step_number": 8,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A20)",
            "(A20 -> A19)"
          ],
          "conclusion": "(-G -> A19)",
          "natural": "Provided that compound X is not profitable, compound X has patent protection."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A19)",
            "-A19"
          ],
          "conclusion": "G",
          "natural": "Compound X is a profitable product."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Manufacturing",
    "atomic_facts": {
      "A1": "approved_for_research(compound_x)",
      "A2": "clinical_trial_success(compound_x)",
      "A3": "regulatory_approval(compound_x)",
      "A4": "market_authorization(compound_x)",
      "A5": "production_scale_up(compound_x)",
      "A6": "manufacturing_optimization(compound_x)",
      "A7": "supply_chain_issue(compound_x)",
      "A8": "raw_material_shortage(excipient_y)",
      "A9": "supplier_delay(excipient_y)",
      "A10": "quality_test_failure(batch_z)",
      "A11": "contamination_detected(batch_z)",
      "A12": "stability_study_pass(formulation_w)",
      "A13": "accelerated_aging_test(formulation_w)",
      "A14": "real_time_stability(formulation_w)",
      "A15": "product_recall(batch_z)",
      "A16": "batch_rejection(batch_z)",
      "A17": "quality_control_inspection(plant_a)",
      "A18": "audit_finding(plant_a)",
      "A19": "patent_protection(compound_x)",
      "A20": "patent_filing(compound_x)",
      "A21": "intellectual_property(compound_x)",
      "A22": "prior_art_search(compound_x)",
      "A23": "patent_rejection(compound_x)",
      "A24": "process_validation(manufacturing_line_b)",
      "A25": "equipment_qualification(manufacturing_line_b)",
      "A26": "validation_protocol(manufacturing_line_b)",
      "A27": "qualification_study(manufacturing_line_b)",
      "A28": "phase_iii_completion(compound_x)",
      "A29": "efficacy_data(compound_x)",
      "A30": "safety_profile(compound_x)",
      "A31": "adverse_events(compound_x)",
      "A32": "dissolution_test(pill_form)",
      "A33": "bioavailability_study(pill_form)",
      "A34": "formulation_change(compound_x)",
      "A35": "excipient_modification(compound_x)",
      "A36": "delivery_system_update(compound_x)",
      "A37": "shelf_life_extension(compound_x)",
      "A38": "packaging_redesign(compound_x)",
      "A39": "process_improvement(manufacturing_line_b)",
      "A40": "equipment_upgrade(manufacturing_line_b)",
      "A41": "capa_implementation(manufacturing_line_b)",
      "A42": "deviation_management(manufacturing_line_b)",
      "G": "profitable_product(compound_x)"
    },
    "natural_facts": {
      "A1": "Compound X is approved for research.",
      "A2": "Compound X has achieved clinical trial success.",
      "A3": "Compound X has obtained regulatory approval.",
      "A4": "Compound X has received market authorization.",
      "A5": "Compound X has undergone production scale-up.",
      "A6": "Compound X has undergone manufacturing optimization.",
      "A7": "Compound X is experiencing supply chain issues.",
      "A8": "Excipient Y is experiencing raw material shortage.",
      "A9": "Excipient Y is experiencing supplier delay.",
      "A10": "Batch Z has failed quality testing.",
      "A11": "Contamination has been detected in batch Z.",
      "A12": "Formulation W has passed stability study.",
      "A13": "Formulation W has undergone accelerated aging testing.",
      "A14": "Formulation W is undergoing real-time stability testing.",
      "A15": "Batch Z has been subject to product recall.",
      "A16": "Batch Z has been rejected.",
      "A17": "Plant A has undergone quality control inspection.",
      "A18": "Plant A has audit findings.",
      "A19": "Compound X has patent protection.",
      "A20": "Compound X has patent filing.",
      "A21": "Compound X has intellectual property protection.",
      "A22": "Compound X has undergone prior art search.",
      "A23": "Compound X has patent rejection.",
      "A24": "Manufacturing line B has undergone process validation.",
      "A25": "Manufacturing line B has equipment qualification.",
      "A26": "Manufacturing line B has validation protocol.",
      "A27": "Manufacturing line B has qualification study.",
      "A28": "Compound X has completed Phase III trials.",
      "A29": "Compound X has efficacy data.",
      "A30": "Compound X has safety profile data.",
      "A31": "Compound X has adverse events.",
      "A32": "Pill form has undergone dissolution testing.",
      "A33": "Pill form has undergone bioavailability study.",
      "A34": "Compound X has formulation changes.",
      "A35": "Compound X has excipient modifications.",
      "A36": "Compound X has delivery system updates.",
      "A37": "Compound X has shelf life extension.",
      "A38": "Compound X has packaging redesign.",
      "A39": "Manufacturing line B has process improvements.",
      "A40": "Manufacturing line B has equipment upgrades.",
      "A41": "Manufacturing line B has CAPA implementation.",
      "A42": "Manufacturing line B has deviation management.",
      "G": "Compound X is a profitable product."
    },
    "prover9_expressions": [
      "(quality_test_failure(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
      "(quality_test_failure(batch_z) | contamination_detected(batch_z))",
      "(contamination_detected(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
      "(stability_study_pass(formulation_w) | profitable_product(compound_x))",
      "(accelerated_aging_test(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
      "(accelerated_aging_test(formulation_w) | real_time_stability(formulation_w))",
      "(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
      "(batch_rejection(batch_z) -> product_recall(batch_z))",
      "(quality_control_inspection(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
      "(quality_control_inspection(plant_a) | audit_finding(plant_a))",
      "(audit_finding(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
      "(patent_filing(compound_x) -> patent_protection(compound_x))",
      "(patent_filing(compound_x) -> intellectual_property(compound_x))",
      "(intellectual_property(compound_x) -> patent_protection(compound_x))",
      "(prior_art_search(compound_x) -> (intellectual_property(compound_x) -> patent_protection(compound_x)))",
      "(process_validation(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
      "(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b))",
      "(equipment_qualification(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
      "(validation_protocol(manufacturing_line_b) -> process_validation(manufacturing_line_b))",
      "(validation_protocol(manufacturing_line_b) | qualification_study(manufacturing_line_b))",
      "(qualification_study(manufacturing_line_b) -> equipment_qualification(manufacturing_line_b))",
      "(phase_iii_completion(compound_x) -> regulatory_approval(compound_x))",
      "(safety_profile(compound_x) | -efficacy_data(compound_x))",
      "(dissolution_test(pill_form) -> stability_study_pass(formulation_w))",
      "(dissolution_test(pill_form) | bioavailability_study(pill_form))",
      "(bioavailability_study(pill_form) -> profitable_product(compound_x))",
      "(excipient_modification(compound_x) -> formulation_change(compound_x))",
      "(excipient_modification(compound_x) -> delivery_system_update(compound_x))",
      "(delivery_system_update(compound_x) -> formulation_change(compound_x))",
      "(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x)))",
      "(market_authorization(compound_x) -> regulatory_approval(compound_x))",
      "(equipment_upgrade(manufacturing_line_b) -> process_improvement(manufacturing_line_b))",
      "(capa_implementation(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
      "(capa_implementation(manufacturing_line_b) | deviation_management(manufacturing_line_b))",
      "(deviation_management(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
      "(production_scale_up(compound_x) -> profitable_product(compound_x))",
      "(production_scale_up(compound_x) | manufacturing_optimization(compound_x))",
      "(manufacturing_optimization(compound_x) -> profitable_product(compound_x))",
      "(supply_chain_issue(compound_x) | (production_scale_up(compound_x) -> profitable_product(compound_x)))",
      "(raw_material_shortage(excipient_y) -> -supply_chain_issue(compound_x))",
      "(raw_material_shortage(excipient_y) | supplier_delay(excipient_y))",
      "(supplier_delay(excipient_y) -> -supply_chain_issue(compound_x))",
      "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> product_recall(batch_z))",
      "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z))",
      "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> -product_recall(batch_z))",
      "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> process_improvement(manufacturing_line_b))",
      "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b))",
      "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> -process_improvement(manufacturing_line_b))",
      "(-(phase_iii_completion(compound_x) -> regulatory_approval(compound_x)) -> efficacy_data(compound_x))",
      "(-(safety_profile(compound_x) | -efficacy_data(compound_x)) -> adverse_events(compound_x))",
      "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> formulation_change(compound_x))",
      "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> excipient_modification(compound_x))",
      "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> -formulation_change(compound_x))",
      "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> packaging_redesign(compound_x))",
      "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> -packaging_redesign(compound_x))",
      "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> phase_iii_completion(compound_x))",
      "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> regulatory_approval(compound_x))",
      "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> market_authorization(compound_x))",
      "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> -regulatory_approval(compound_x))",
      "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x))",
      "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> -clinical_trial_success(compound_x))",
      "(-prior_art_search(compound_x) -> patent_rejection(compound_x))",
      "(-prior_art_search(compound_x) -> -patent_rejection(compound_x))",
      "(-profitable_product(compound_x) -> approved_for_research(compound_x))",
      "(-profitable_product(compound_x) -> patent_protection(compound_x))",
      "(-profitable_product(compound_x) -> patent_filing(compound_x))",
      "(-profitable_product(compound_x) -> -approved_for_research(compound_x))",
      "prior_art_search(compound_x)",
      "profitable_product(compound_x)",
      "-stability_study_pass(formulation_w)",
      "-patent_protection(compound_x)",
      "-efficacy_data(compound_x)",
      "-safety_profile(compound_x)",
      "-adverse_events(compound_x)",
      "-shelf_life_extension(compound_x)",
      "-supply_chain_issue(compound_x)"
    ],
    "natural_expressions": [
      "If batch Z fails quality testing, then either excipient Y experiences raw material shortage or excipient Y experiences supplier delay.",
      "Either batch Z fails quality testing or contamination is detected in batch Z.",
      "Provided that contamination is detected in batch Z, it follows that either excipient Y has raw material shortage or excipient Y has supplier delay.",
      "Formulation W passes stability study or compound X is a profitable product.",
      "Whenever formulation W undergoes accelerated aging testing, either formulation W passes stability study or compound X becomes profitable.",
      "Formulation W undergoes accelerated aging testing or formulation W undergoes real-time stability testing.",
      "Under the condition that formulation W undergoes real-time stability testing, either formulation W passes stability study or compound X is profitable.",
      "If batch Z is rejected, then batch Z is subject to product recall.",
      "Provided that plant A undergoes quality control inspection, if it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected.",
      "Either plant A undergoes quality control inspection or plant A has audit findings.",
      "Whenever plant A has audit findings, if it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected.",
      "If compound X has patent filing, then compound X has patent protection.",
      "Provided that compound X has patent filing, it follows that compound X has intellectual property protection.",
      "Whenever compound X has intellectual property protection, compound X has patent protection.",
      "Under the condition that compound X undergoes prior art search, if compound X has intellectual property protection then compound X has patent protection.",
      "If manufacturing line B undergoes process validation, then provided that compound X does not undergo prior art search, compound X receives patent rejection.",
      "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification.",
      "Whenever manufacturing line B has equipment qualification, if compound X does not undergo prior art search then compound X receives patent rejection.",
      "If manufacturing line B has validation protocol, then manufacturing line B undergoes process validation.",
      "Either manufacturing line B has validation protocol or manufacturing line B has qualification study.",
      "Provided that manufacturing line B has qualification study, it follows that manufacturing line B has equipment qualification.",
      "Whenever compound X completes Phase III trials, compound X obtains regulatory approval.",
      "Either compound X has safety profile data or compound X does not have efficacy data.",
      "If pill form undergoes dissolution testing, then formulation W passes stability study.",
      "Either pill form undergoes dissolution testing or pill form undergoes bioavailability study.",
      "Under the condition that pill form undergoes bioavailability study, compound X becomes profitable.",
      "If compound X has excipient modifications, then compound X has formulation changes.",
      "Provided that compound X has excipient modifications, compound X has delivery system updates.",
      "Whenever compound X has delivery system updates, compound X has formulation changes.",
      "Either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes.",
      "If compound X receives market authorization, then compound X obtains regulatory approval.",
      "Whenever manufacturing line B has equipment upgrades, manufacturing line B has process improvements.",
      "Provided that manufacturing line B has CAPA implementation, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades.",
      "Either manufacturing line B has CAPA implementation or manufacturing line B has deviation management.",
      "Under the condition that manufacturing line B has deviation management, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades.",
      "If compound X undergoes production scale-up, then compound X is profitable.",
      "Either compound X undergoes production scale-up or compound X undergoes manufacturing optimization.",
      "Whenever compound X undergoes manufacturing optimization, compound X becomes profitable.",
      "Either compound X experiences supply chain issues or if compound X undergoes production scale-up then compound X is profitable.",
      "If excipient Y has raw material shortage, then compound X does not experience supply chain issues.",
      "Either excipient Y has raw material shortage or excipient Y has supplier delay.",
      "Provided that excipient Y has supplier delay, compound X does not experience supply chain issues.",
      "If it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is subject to product recall.",
      "Whenever it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is rejected.",
      "Provided that it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is not subject to product recall.",
      "If it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has process improvements.",
      "Under the condition that it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B has equipment upgrades.",
      "Whenever it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B does not have process improvements.",
      "If it is not the case that whenever compound X completes Phase III trials then compound X obtains regulatory approval, then compound X has efficacy data.",
      "Provided that it is not the case that either compound X has safety profile data or compound X does not have efficacy data, compound X has adverse events.",
      "Under the condition that it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has formulation changes.",
      "Whenever it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has excipient modifications.",
      "If it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, then compound X does not have formulation changes.",
      "Provided that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X has packaging redesign.",
      "Under the condition that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X does not have packaging redesign.",
      "If it is not the case that whenever it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, then compound X completes Phase III trials.",
      "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval.",
      "Whenever it is not the case that if it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X receives market authorization.",
      "Under the condition that it is not the case that provided that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X does not obtain regulatory approval.",
      "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success.",
      "Provided that it is not the case that if compound X is not profitable then compound X is not approved for research, compound X does not have clinical trial success.",
      "Whenever compound X does not undergo prior art search, compound X receives patent rejection.",
      "Under the condition that compound X does not undergo prior art search, compound X does not receive patent rejection.",
      "If compound X is not profitable, then compound X is approved for research.",
      "Provided that compound X is not profitable, compound X has patent protection.",
      "Whenever compound X is not profitable, compound X has patent filing.",
      "Under the condition that compound X is not profitable, compound X is not approved for research.",
      "Compound X undergoes prior art search.",
      "Compound X is a profitable product.",
      "Formulation W does not pass stability study.",
      "Compound X does not have patent protection.",
      "Compound X does not have efficacy data.",
      "Compound X does not have safety profile data.",
      "Compound X does not have adverse events.",
      "Compound X does not have shelf life extension.",
      "Compound X does not experience supply chain issues."
    ],
    "node_mappings": {
      "(A10 → (A8 ∨ A9))": {
        "formal": "(A10 → (A8 ∨ A9))",
        "prover9": "(A10 -> (A8 | A9))",
        "prover9_expression": "(quality_test_failure(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
        "natural": "If batch Z fails quality testing, then either excipient Y experiences raw material shortage or excipient Y experiences supplier delay."
      },
      "(A10 ∨ A11)": {
        "formal": "(A10 ∨ A11)",
        "prover9": "(A10 | A11)",
        "prover9_expression": "(quality_test_failure(batch_z) | contamination_detected(batch_z))",
        "natural": "Either batch Z fails quality testing or contamination is detected in batch Z."
      },
      "(A11 → (A8 ∨ A9))": {
        "formal": "(A11 → (A8 ∨ A9))",
        "prover9": "(A11 -> (A8 | A9))",
        "prover9_expression": "(contamination_detected(batch_z) -> (raw_material_shortage(excipient_y) | supplier_delay(excipient_y)))",
        "natural": "Provided that contamination is detected in batch Z, it follows that either excipient Y has raw material shortage or excipient Y has supplier delay."
      },
      "(A12 ∨ G)": {
        "formal": "(A12 ∨ G)",
        "prover9": "(A12 | G)",
        "prover9_expression": "(stability_study_pass(formulation_w) | profitable_product(compound_x))",
        "natural": "Formulation W passes stability study or compound X is a profitable product."
      },
      "(A13 → (A12 ∨ G))": {
        "formal": "(A13 → (A12 ∨ G))",
        "prover9": "(A13 -> (A12 | G))",
        "prover9_expression": "(accelerated_aging_test(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
        "natural": "Whenever formulation W undergoes accelerated aging testing, either formulation W passes stability study or compound X becomes profitable."
      },
      "(A13 ∨ A14)": {
        "formal": "(A13 ∨ A14)",
        "prover9": "(A13 | A14)",
        "prover9_expression": "(accelerated_aging_test(formulation_w) | real_time_stability(formulation_w))",
        "natural": "Formulation W undergoes accelerated aging testing or formulation W undergoes real-time stability testing."
      },
      "(A14 → (A12 ∨ G))": {
        "formal": "(A14 → (A12 ∨ G))",
        "prover9": "(A14 -> (A12 | G))",
        "prover9_expression": "(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x)))",
        "natural": "Under the condition that formulation W undergoes real-time stability testing, either formulation W passes stability study or compound X is profitable."
      },
      "(A16 → A15)": {
        "formal": "(A16 → A15)",
        "prover9": "(A16 -> A15)",
        "prover9_expression": "(batch_rejection(batch_z) -> product_recall(batch_z))",
        "natural": "If batch Z is rejected, then batch Z is subject to product recall."
      },
      "(A17 → (¬(A14 → (A12 ∨ G)) → A16))": {
        "formal": "(A17 → (¬(A14 → (A12 ∨ G)) → A16))",
        "prover9": "(A17 -> (-(A14 -> (A12 | G)) -> A16))",
        "prover9_expression": "(quality_control_inspection(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
        "natural": "Provided that plant A undergoes quality control inspection, if it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
      },
      "(A17 ∨ A18)": {
        "formal": "(A17 ∨ A18)",
        "prover9": "(A17 | A18)",
        "prover9_expression": "(quality_control_inspection(plant_a) | audit_finding(plant_a))",
        "natural": "Either plant A undergoes quality control inspection or plant A has audit findings."
      },
      "(A18 → (¬(A14 → (A12 ∨ G)) → A16))": {
        "formal": "(A18 → (¬(A14 → (A12 ∨ G)) → A16))",
        "prover9": "(A18 -> (-(A14 -> (A12 | G)) -> A16))",
        "prover9_expression": "(audit_finding(plant_a) -> (-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z)))",
        "natural": "Whenever plant A has audit findings, if it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is rejected."
      },
      "(A20 → A19)": {
        "formal": "(A20 → A19)",
        "prover9": "(A20 -> A19)",
        "prover9_expression": "(patent_filing(compound_x) -> patent_protection(compound_x))",
        "natural": "If compound X has patent filing, then compound X has patent protection."
      },
      "(A20 → A21)": {
        "formal": "(A20 → A21)",
        "prover9": "(A20 -> A21)",
        "prover9_expression": "(patent_filing(compound_x) -> intellectual_property(compound_x))",
        "natural": "Provided that compound X has patent filing, it follows that compound X has intellectual property protection."
      },
      "(A21 → A19)": {
        "formal": "(A21 → A19)",
        "prover9": "(A21 -> A19)",
        "prover9_expression": "(intellectual_property(compound_x) -> patent_protection(compound_x))",
        "natural": "Whenever compound X has intellectual property protection, compound X has patent protection."
      },
      "(A22 → (A21 → A19))": {
        "formal": "(A22 → (A21 → A19))",
        "prover9": "(A22 -> (A21 -> A19))",
        "prover9_expression": "(prior_art_search(compound_x) -> (intellectual_property(compound_x) -> patent_protection(compound_x)))",
        "natural": "Under the condition that compound X undergoes prior art search, if compound X has intellectual property protection then compound X has patent protection."
      },
      "(A24 → (¬A22 → A23))": {
        "formal": "(A24 → (¬A22 → A23))",
        "prover9": "(A24 -> (-A22 -> A23))",
        "prover9_expression": "(process_validation(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
        "natural": "If manufacturing line B undergoes process validation, then provided that compound X does not undergo prior art search, compound X receives patent rejection."
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b))",
        "natural": "Either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification."
      },
      "(A25 → (¬A22 → A23))": {
        "formal": "(A25 → (¬A22 → A23))",
        "prover9": "(A25 -> (-A22 -> A23))",
        "prover9_expression": "(equipment_qualification(manufacturing_line_b) -> (-prior_art_search(compound_x) -> patent_rejection(compound_x)))",
        "natural": "Whenever manufacturing line B has equipment qualification, if compound X does not undergo prior art search then compound X receives patent rejection."
      },
      "(A26 → A24)": {
        "formal": "(A26 → A24)",
        "prover9": "(A26 -> A24)",
        "prover9_expression": "(validation_protocol(manufacturing_line_b) -> process_validation(manufacturing_line_b))",
        "natural": "If manufacturing line B has validation protocol, then manufacturing line B undergoes process validation."
      },
      "(A26 ∨ A27)": {
        "formal": "(A26 ∨ A27)",
        "prover9": "(A26 | A27)",
        "prover9_expression": "(validation_protocol(manufacturing_line_b) | qualification_study(manufacturing_line_b))",
        "natural": "Either manufacturing line B has validation protocol or manufacturing line B has qualification study."
      },
      "(A27 → A25)": {
        "formal": "(A27 → A25)",
        "prover9": "(A27 -> A25)",
        "prover9_expression": "(qualification_study(manufacturing_line_b) -> equipment_qualification(manufacturing_line_b))",
        "natural": "Provided that manufacturing line B has qualification study, it follows that manufacturing line B has equipment qualification."
      },
      "(A28 → A3)": {
        "formal": "(A28 → A3)",
        "prover9": "(A28 -> A3)",
        "prover9_expression": "(phase_iii_completion(compound_x) -> regulatory_approval(compound_x))",
        "natural": "Whenever compound X completes Phase III trials, compound X obtains regulatory approval."
      },
      "(A30 ∨ ¬A29)": {
        "formal": "(A30 ∨ ¬A29)",
        "prover9": "(A30 | -A29)",
        "prover9_expression": "(safety_profile(compound_x) | -efficacy_data(compound_x))",
        "natural": "Either compound X has safety profile data or compound X does not have efficacy data."
      },
      "(A32 → A12)": {
        "formal": "(A32 → A12)",
        "prover9": "(A32 -> A12)",
        "prover9_expression": "(dissolution_test(pill_form) -> stability_study_pass(formulation_w))",
        "natural": "If pill form undergoes dissolution testing, then formulation W passes stability study."
      },
      "(A32 ∨ A33)": {
        "formal": "(A32 ∨ A33)",
        "prover9": "(A32 | A33)",
        "prover9_expression": "(dissolution_test(pill_form) | bioavailability_study(pill_form))",
        "natural": "Either pill form undergoes dissolution testing or pill form undergoes bioavailability study."
      },
      "(A33 → G)": {
        "formal": "(A33 → G)",
        "prover9": "(A33 -> G)",
        "prover9_expression": "(bioavailability_study(pill_form) -> profitable_product(compound_x))",
        "natural": "Under the condition that pill form undergoes bioavailability study, compound X becomes profitable."
      },
      "(A35 → A34)": {
        "formal": "(A35 → A34)",
        "prover9": "(A35 -> A34)",
        "prover9_expression": "(excipient_modification(compound_x) -> formulation_change(compound_x))",
        "natural": "If compound X has excipient modifications, then compound X has formulation changes."
      },
      "(A35 → A36)": {
        "formal": "(A35 → A36)",
        "prover9": "(A35 -> A36)",
        "prover9_expression": "(excipient_modification(compound_x) -> delivery_system_update(compound_x))",
        "natural": "Provided that compound X has excipient modifications, compound X has delivery system updates."
      },
      "(A36 → A34)": {
        "formal": "(A36 → A34)",
        "prover9": "(A36 -> A34)",
        "prover9_expression": "(delivery_system_update(compound_x) -> formulation_change(compound_x))",
        "natural": "Whenever compound X has delivery system updates, compound X has formulation changes."
      },
      "(A37 ∨ (A36 → A34))": {
        "formal": "(A37 ∨ (A36 → A34))",
        "prover9": "(A37 | (A36 -> A34))",
        "prover9_expression": "(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x)))",
        "natural": "Either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes."
      },
      "(A4 → A3)": {
        "formal": "(A4 → A3)",
        "prover9": "(A4 -> A3)",
        "prover9_expression": "(market_authorization(compound_x) -> regulatory_approval(compound_x))",
        "natural": "If compound X receives market authorization, then compound X obtains regulatory approval."
      },
      "(A40 → A39)": {
        "formal": "(A40 → A39)",
        "prover9": "(A40 -> A39)",
        "prover9_expression": "(equipment_upgrade(manufacturing_line_b) -> process_improvement(manufacturing_line_b))",
        "natural": "Whenever manufacturing line B has equipment upgrades, manufacturing line B has process improvements."
      },
      "(A41 → (¬(A24 ∨ A25) → A40))": {
        "formal": "(A41 → (¬(A24 ∨ A25) → A40))",
        "prover9": "(A41 -> (-(A24 | A25) -> A40))",
        "prover9_expression": "(capa_implementation(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
        "natural": "Provided that manufacturing line B has CAPA implementation, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
      },
      "(A41 ∨ A42)": {
        "formal": "(A41 ∨ A42)",
        "prover9": "(A41 | A42)",
        "prover9_expression": "(capa_implementation(manufacturing_line_b) | deviation_management(manufacturing_line_b))",
        "natural": "Either manufacturing line B has CAPA implementation or manufacturing line B has deviation management."
      },
      "(A42 → (¬(A24 ∨ A25) → A40))": {
        "formal": "(A42 → (¬(A24 ∨ A25) → A40))",
        "prover9": "(A42 -> (-(A24 | A25) -> A40))",
        "prover9_expression": "(deviation_management(manufacturing_line_b) -> (-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b)))",
        "natural": "Under the condition that manufacturing line B has deviation management, if it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has equipment upgrades."
      },
      "(A5 → G)": {
        "formal": "(A5 → G)",
        "prover9": "(A5 -> G)",
        "prover9_expression": "(production_scale_up(compound_x) -> profitable_product(compound_x))",
        "natural": "If compound X undergoes production scale-up, then compound X is profitable."
      },
      "(A5 ∨ A6)": {
        "formal": "(A5 ∨ A6)",
        "prover9": "(A5 | A6)",
        "prover9_expression": "(production_scale_up(compound_x) | manufacturing_optimization(compound_x))",
        "natural": "Either compound X undergoes production scale-up or compound X undergoes manufacturing optimization."
      },
      "(A6 → G)": {
        "formal": "(A6 → G)",
        "prover9": "(A6 -> G)",
        "prover9_expression": "(manufacturing_optimization(compound_x) -> profitable_product(compound_x))",
        "natural": "Whenever compound X undergoes manufacturing optimization, compound X becomes profitable."
      },
      "(A7 ∨ (A5 → G))": {
        "formal": "(A7 ∨ (A5 → G))",
        "prover9": "(A7 | (A5 -> G))",
        "prover9_expression": "(supply_chain_issue(compound_x) | (production_scale_up(compound_x) -> profitable_product(compound_x)))",
        "natural": "Either compound X experiences supply chain issues or if compound X undergoes production scale-up then compound X is profitable."
      },
      "(A8 → ¬A7)": {
        "formal": "(A8 → ¬A7)",
        "prover9": "(A8 -> -A7)",
        "prover9_expression": "(raw_material_shortage(excipient_y) -> -supply_chain_issue(compound_x))",
        "natural": "If excipient Y has raw material shortage, then compound X does not experience supply chain issues."
      },
      "(A8 ∨ A9)": {
        "formal": "(A8 ∨ A9)",
        "prover9": "(A8 | A9)",
        "prover9_expression": "(raw_material_shortage(excipient_y) | supplier_delay(excipient_y))",
        "natural": "Either excipient Y has raw material shortage or excipient Y has supplier delay."
      },
      "(A9 → ¬A7)": {
        "formal": "(A9 → ¬A7)",
        "prover9": "(A9 -> -A7)",
        "prover9_expression": "(supplier_delay(excipient_y) -> -supply_chain_issue(compound_x))",
        "natural": "Provided that excipient Y has supplier delay, compound X does not experience supply chain issues."
      },
      "(¬(A14 → (A12 ∨ G)) → A15)": {
        "formal": "(¬(A14 → (A12 ∨ G)) → A15)",
        "prover9": "(-(A14 -> (A12 | G)) -> A15)",
        "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> product_recall(batch_z))",
        "natural": "If it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, then batch Z is subject to product recall."
      },
      "(¬(A14 → (A12 ∨ G)) → A16)": {
        "formal": "(¬(A14 → (A12 ∨ G)) → A16)",
        "prover9": "(-(A14 -> (A12 | G)) -> A16)",
        "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> batch_rejection(batch_z))",
        "natural": "Whenever it is not the case that whenever formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is rejected."
      },
      "(¬(A14 → (A12 ∨ G)) → ¬A15)": {
        "formal": "(¬(A14 → (A12 ∨ G)) → ¬A15)",
        "prover9": "(-(A14 -> (A12 | G)) -> -A15)",
        "prover9_expression": "(-(real_time_stability(formulation_w) -> (stability_study_pass(formulation_w) | profitable_product(compound_x))) -> -product_recall(batch_z))",
        "natural": "Provided that it is not the case that under the condition that formulation W undergoes real-time stability testing then either formulation W passes stability study or compound X is profitable, batch Z is not subject to product recall."
      },
      "(¬(A24 ∨ A25) → A39)": {
        "formal": "(¬(A24 ∨ A25) → A39)",
        "prover9": "(-(A24 | A25) -> A39)",
        "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> process_improvement(manufacturing_line_b))",
        "natural": "If it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, then manufacturing line B has process improvements."
      },
      "(¬(A24 ∨ A25) → A40)": {
        "formal": "(¬(A24 ∨ A25) → A40)",
        "prover9": "(-(A24 | A25) -> A40)",
        "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> equipment_upgrade(manufacturing_line_b))",
        "natural": "Under the condition that it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B has equipment upgrades."
      },
      "(¬(A24 ∨ A25) → ¬A39)": {
        "formal": "(¬(A24 ∨ A25) → ¬A39)",
        "prover9": "(-(A24 | A25) -> -A39)",
        "prover9_expression": "(-(process_validation(manufacturing_line_b) | equipment_qualification(manufacturing_line_b)) -> -process_improvement(manufacturing_line_b))",
        "natural": "Whenever it is not the case that either manufacturing line B undergoes process validation or manufacturing line B has equipment qualification, manufacturing line B does not have process improvements."
      },
      "(¬(A28 → A3) → A29)": {
        "formal": "(¬(A28 → A3) → A29)",
        "prover9": "(-(A28 -> A3) -> A29)",
        "prover9_expression": "(-(phase_iii_completion(compound_x) -> regulatory_approval(compound_x)) -> efficacy_data(compound_x))",
        "natural": "If it is not the case that whenever compound X completes Phase III trials then compound X obtains regulatory approval, then compound X has efficacy data."
      },
      "(¬(A30 ∨ ¬A29) → A31)": {
        "formal": "(¬(A30 ∨ ¬A29) → A31)",
        "prover9": "(-(A30 | -A29) -> A31)",
        "prover9_expression": "(-(safety_profile(compound_x) | -efficacy_data(compound_x)) -> adverse_events(compound_x))",
        "natural": "Provided that it is not the case that either compound X has safety profile data or compound X does not have efficacy data, compound X has adverse events."
      },
      "(¬(A32 ∨ A33) → A34)": {
        "formal": "(¬(A32 ∨ A33) → A34)",
        "prover9": "(-(A32 | A33) -> A34)",
        "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> formulation_change(compound_x))",
        "natural": "Under the condition that it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has formulation changes."
      },
      "(¬(A32 ∨ A33) → A35)": {
        "formal": "(¬(A32 ∨ A33) → A35)",
        "prover9": "(-(A32 | A33) -> A35)",
        "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> excipient_modification(compound_x))",
        "natural": "Whenever it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, compound X has excipient modifications."
      },
      "(¬(A32 ∨ A33) → ¬A34)": {
        "formal": "(¬(A32 ∨ A33) → ¬A34)",
        "prover9": "(-(A32 | A33) -> -A34)",
        "prover9_expression": "(-(dissolution_test(pill_form) | bioavailability_study(pill_form)) -> -formulation_change(compound_x))",
        "natural": "If it is not the case that either pill form undergoes dissolution testing or pill form undergoes bioavailability study, then compound X does not have formulation changes."
      },
      "(¬(A37 ∨ (A36 → A34)) → A38)": {
        "formal": "(¬(A37 ∨ (A36 → A34)) → A38)",
        "prover9": "(-(A37 | (A36 -> A34)) -> A38)",
        "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> packaging_redesign(compound_x))",
        "natural": "Provided that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X has packaging redesign."
      },
      "(¬(A37 ∨ (A36 → A34)) → ¬A38)": {
        "formal": "(¬(A37 ∨ (A36 → A34)) → ¬A38)",
        "prover9": "(-(A37 | (A36 -> A34)) -> -A38)",
        "prover9_expression": "(-(shelf_life_extension(compound_x) | (delivery_system_update(compound_x) -> formulation_change(compound_x))) -> -packaging_redesign(compound_x))",
        "natural": "Under the condition that it is not the case that either compound X has shelf life extension or if compound X has delivery system updates then compound X has formulation changes, compound X does not have packaging redesign."
      },
      "(¬(¬(¬G → ¬A1) → A2) → A28)": {
        "formal": "(¬(¬(¬G → ¬A1) → A2) → A28)",
        "prover9": "(-(-(-G -> -A1) -> A2) -> A28)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> phase_iii_completion(compound_x))",
        "natural": "If it is not the case that whenever it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, then compound X completes Phase III trials."
      },
      "(¬(¬(¬G → ¬A1) → A2) → A3)": {
        "formal": "(¬(¬(¬G → ¬A1) → A2) → A3)",
        "prover9": "(-(-(-G -> -A1) -> A2) -> A3)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> regulatory_approval(compound_x))",
        "natural": "Provided that it is not the case that under the condition that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X obtains regulatory approval."
      },
      "(¬(¬(¬G → ¬A1) → A2) → A4)": {
        "formal": "(¬(¬(¬G → ¬A1) → A2) → A4)",
        "prover9": "(-(-(-G -> -A1) -> A2) -> A4)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> market_authorization(compound_x))",
        "natural": "Whenever it is not the case that if it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X receives market authorization."
      },
      "(¬(¬(¬G → ¬A1) → A2) → ¬A3)": {
        "formal": "(¬(¬(¬G → ¬A1) → A2) → ¬A3)",
        "prover9": "(-(-(-G -> -A1) -> A2) -> -A3)",
        "prover9_expression": "(-(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x)) -> -regulatory_approval(compound_x))",
        "natural": "Under the condition that it is not the case that provided that it is not the case that if compound X is not profitable then compound X is not approved for research then compound X has clinical trial success, compound X does not obtain regulatory approval."
      },
      "(¬(¬G → ¬A1) → A2)": {
        "formal": "(¬(¬G → ¬A1) → A2)",
        "prover9": "(-(-G -> -A1) -> A2)",
        "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> clinical_trial_success(compound_x))",
        "natural": "If it is not the case that if compound X is not profitable then compound X is not approved for research, then compound X has clinical trial success."
      },
      "(¬(¬G → ¬A1) → ¬A2)": {
        "formal": "(¬(¬G → ¬A1) → ¬A2)",
        "prover9": "(-(-G -> -A1) -> -A2)",
        "prover9_expression": "(-(-profitable_product(compound_x) -> -approved_for_research(compound_x)) -> -clinical_trial_success(compound_x))",
        "natural": "Provided that it is not the case that if compound X is not profitable then compound X is not approved for research, compound X does not have clinical trial success."
      },
      "(¬A22 → A23)": {
        "formal": "(¬A22 → A23)",
        "prover9": "(-A22 -> A23)",
        "prover9_expression": "(-prior_art_search(compound_x) -> patent_rejection(compound_x))",
        "natural": "Whenever compound X does not undergo prior art search, compound X receives patent rejection."
      },
      "(¬A22 → ¬A23)": {
        "formal": "(¬A22 → ¬A23)",
        "prover9": "(-A22 -> -A23)",
        "prover9_expression": "(-prior_art_search(compound_x) -> -patent_rejection(compound_x))",
        "natural": "Under the condition that compound X does not undergo prior art search, compound X does not receive patent rejection."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-profitable_product(compound_x) -> approved_for_research(compound_x))",
        "natural": "If compound X is not profitable, then compound X is approved for research."
      },
      "(¬G → A19)": {
        "formal": "(¬G → A19)",
        "prover9": "(-G -> A19)",
        "prover9_expression": "(-profitable_product(compound_x) -> patent_protection(compound_x))",
        "natural": "Provided that compound X is not profitable, compound X has patent protection."
      },
      "(¬G → A20)": {
        "formal": "(¬G → A20)",
        "prover9": "(-G -> A20)",
        "prover9_expression": "(-profitable_product(compound_x) -> patent_filing(compound_x))",
        "natural": "Whenever compound X is not profitable, compound X has patent filing."
      },
      "(¬G → ¬A1)": {
        "formal": "(¬G → ¬A1)",
        "prover9": "(-G -> -A1)",
        "prover9_expression": "(-profitable_product(compound_x) -> -approved_for_research(compound_x))",
        "natural": "Under the condition that compound X is not profitable, compound X is not approved for research."
      },
      "A22": {
        "formal": "A22",
        "prover9": "A22",
        "prover9_expression": "prior_art_search(compound_x)",
        "natural": "Compound X undergoes prior art search."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "profitable_product(compound_x)",
        "natural": "Compound X is a profitable product."
      },
      "¬A12": {
        "formal": "¬A12",
        "prover9": "-A12",
        "prover9_expression": "-stability_study_pass(formulation_w)",
        "natural": "Formulation W does not pass stability study."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-patent_protection(compound_x)",
        "natural": "Compound X does not have patent protection."
      },
      "¬A29": {
        "formal": "¬A29",
        "prover9": "-A29",
        "prover9_expression": "-efficacy_data(compound_x)",
        "natural": "Compound X does not have efficacy data."
      },
      "¬A30": {
        "formal": "¬A30",
        "prover9": "-A30",
        "prover9_expression": "-safety_profile(compound_x)",
        "natural": "Compound X does not have safety profile data."
      },
      "¬A31": {
        "formal": "¬A31",
        "prover9": "-A31",
        "prover9_expression": "-adverse_events(compound_x)",
        "natural": "Compound X does not have adverse events."
      },
      "¬A37": {
        "formal": "¬A37",
        "prover9": "-A37",
        "prover9_expression": "-shelf_life_extension(compound_x)",
        "natural": "Compound X does not have shelf life extension."
      },
      "¬A7": {
        "formal": "¬A7",
        "prover9": "-A7",
        "prover9_expression": "-supply_chain_issue(compound_x)",
        "natural": "Compound X does not experience supply chain issues."
      }
    }
  }
}